Cullinan Therapeutics (CGEM) Revenue (2021)
Historic Revenue for Cullinan Therapeutics (CGEM) over the last 1 years, with Q1 2021 value amounting to $18.9 million.
- Cullinan Therapeutics' Revenue changed N/A to $18.9 million in Q1 2021 from the same period last year, while for Dec 2021 it was $18.9 million, marking a year-over-year change of. This contributed to the annual value of $18.9 million for FY2021, which is N/A changed from last year.
- According to the latest figures from Q1 2021, Cullinan Therapeutics' Revenue is $18.9 million.
- In the past 5 years, Cullinan Therapeutics' Revenue ranged from a high of $18.9 million in Q1 2021 and a low of $18.9 million during Q1 2021